Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia

Enterobacteria contribute to two serious clinical syndromes seen in African AIDS patients: diarrhea and septicemia. In West Africa, prophylaxis with sulfamethoxazole-trimethoprim (SXT) reduced illnesses. We report reduced sensitivity of enterobacteria to available antimicrobial agents in Zambia, wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwansa, James, Mutela, Kabanga, Zulu, Isaac, Amadi, Beatrice, Kelly, Paul
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2002
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730261/
https://www.ncbi.nlm.nih.gov/pubmed/11799759
http://dx.doi.org/10.3201/eid0801.010018
_version_ 1782170872133451776
author Mwansa, James
Mutela, Kabanga
Zulu, Isaac
Amadi, Beatrice
Kelly, Paul
author_facet Mwansa, James
Mutela, Kabanga
Zulu, Isaac
Amadi, Beatrice
Kelly, Paul
author_sort Mwansa, James
collection PubMed
description Enterobacteria contribute to two serious clinical syndromes seen in African AIDS patients: diarrhea and septicemia. In West Africa, prophylaxis with sulfamethoxazole-trimethoprim (SXT) reduced illnesses. We report reduced sensitivity of enterobacteria to available antimicrobial agents in Zambia, with only 22% of nontyphoidal salmonellae and 6% of shigellae sensitive to SXT.
format Text
id pubmed-2730261
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27302612009-09-16 Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia Mwansa, James Mutela, Kabanga Zulu, Isaac Amadi, Beatrice Kelly, Paul Emerg Infect Dis Dispatch Enterobacteria contribute to two serious clinical syndromes seen in African AIDS patients: diarrhea and septicemia. In West Africa, prophylaxis with sulfamethoxazole-trimethoprim (SXT) reduced illnesses. We report reduced sensitivity of enterobacteria to available antimicrobial agents in Zambia, with only 22% of nontyphoidal salmonellae and 6% of shigellae sensitive to SXT. Centers for Disease Control and Prevention 2002-01 /pmc/articles/PMC2730261/ /pubmed/11799759 http://dx.doi.org/10.3201/eid0801.010018 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Mwansa, James
Mutela, Kabanga
Zulu, Isaac
Amadi, Beatrice
Kelly, Paul
Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title_full Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title_fullStr Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title_full_unstemmed Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title_short Antimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
title_sort antimicrobial sensitivity in enterobacteria from aids patients, zambia
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730261/
https://www.ncbi.nlm.nih.gov/pubmed/11799759
http://dx.doi.org/10.3201/eid0801.010018
work_keys_str_mv AT mwansajames antimicrobialsensitivityinenterobacteriafromaidspatientszambia
AT mutelakabanga antimicrobialsensitivityinenterobacteriafromaidspatientszambia
AT zuluisaac antimicrobialsensitivityinenterobacteriafromaidspatientszambia
AT amadibeatrice antimicrobialsensitivityinenterobacteriafromaidspatientszambia
AT kellypaul antimicrobialsensitivityinenterobacteriafromaidspatientszambia

Ejemplares similares